Control_Vehicle_vs_FSCN1_Knockout_Vehicle

Profile details

Identifier: MTBLS6402_0001_00000001
Linked study: MTBLS6402 — FSCN1 as a new druggable target in adrenocortical carcinoma
Comparison: Control_Vehicle vs FSCN1_Knockout_Vehicle
Group A: Control group treated with vehicle. Provides baseline for comparison with FSCN1 knockout under vehicle treatment
Group B: FSCN1 knockout group treated with vehicle. Allows assessment of FSCN1 knockout effects compared to control under vehicle treatment
Total features tested: 37
Significant features: 18
p-value threshold: 0.05
Ratio threshold (upper): 1.5
Ratio threshold (lower): 1/1.5
Date created: 2025-09-26 00:00:00

Metabolite ID (InChI Key)	Name	Direction	Ratio	p-value
KRKNYBCHXYNGOX-UHFFFAOYSA-N	Citronensäure	up	1.98	0.00107
OPVPGKGADVGKTG-BQBZGAKWSA-N	N-Acetyl-1-aspartylglutamic acid	up	1.929	0.00105
DJJCXFVJDGTHFX-XVFCMESISA-N	pU	up	3.186	0.0228
XTWYTFMLZFPYCI-KQYNXXCUSA-N	5'-adenylphosphoric acid	up	2.105	0.00345
YPZRWBKMTBYPTK-BJDJZHNGSA-N	OXIDIZED GLUTATHIONE DISULFIDE	up	2.096	0.00503
GYOZYWVXFNDGLU-XLPZGREQSA-N	Thymidylic acid	up	2.333	0.0107
RQFCJASXJCIDSX-UUOKFMHZSA-N	GMP	up	2.7	0.0263
DRTQHJPVMGBUCF-XVFCMESISA-N	u	up	3.189	0.0459
UDMBCSSLTHHNCD-KQYNXXCUSA-N	Adenosine-5'-monophosphoric acid	up	2.413	0.0231
CBQJSKKFNMDLON-JTQLQIEISA-N	Acetylphenylalanine	up	1.6	0.000946